Back
Allogene Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
ALLO
Allogene Therapeutics, Inc.
Last Price:
$1.41
Seasonality Move:
-2.13%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and ALLO is experiencing slight buying pressure.
Allogene Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.46 | Sell |
| 20-day SMA: | 1.44 | Sell |
| 50-day SMA: | 1.31 | Buy |
| 200-day SMA: | 1.31 | Buy |
| 8-day EMA: | 1.44 | Sell |
| 20-day EMA: | 1.42 | Sell |
| 50-day EMA: | 1.35 | Buy |
| 200-day EMA: | 1.46 | Sell |
Allogene Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 50.21 | Buy |
| Chaikin Money Flow: | 404422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.5) | Sell |
| Bollinger Bands (100): | (1.11 - 1.37) | Buy |
Allogene Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics, Inc. Stock
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 1.40 while ALLO 8-day simple moving average is 1.46, which is a Sell signal.
-
The stock price of ALLO is 1.40 while Allogene Therapeutics, Inc. 20-day SMA is 1.44, which makes it a Sell.
-
Allogene Therapeutics, Inc. 50-day simple moving average is 1.31 while ALLO share price is 1.40, making it a Buy technically.
-
ALLO stock price is 1.40 and Allogene Therapeutics, Inc. 200-day simple moving average is 1.31, creating a Buy signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
50
Allogene Therapeutics, Inc. (ALLO)
is a Sell
Is Allogene Therapeutics, Inc. a Buy or a Sell?
-
Allogene Therapeutics, Inc. stock is rated a SellThe current Allogene Therapeutics, Inc. [ALLO] share price is $1.40. The Score for ALLO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics, Inc. Stock Info
Market Cap:
314.6M
Price in USD:
1.40
Share Volume:
1.1M
Allogene Therapeutics, Inc. 52-Week Range
52-Week High:
3.78
52-Week Low:
0.86
Sell
50
Allogene Therapeutics, Inc. (ALLO)
is a Sell
Allogene Therapeutics, Inc. Share Price Forecast
-
What is the Allogene Therapeutics, Inc. stock price today?The Allogene Therapeutics, Inc. stock price is 1.40 USD today.
-
Will ALLO stock go up or go down?Allogene Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Allogene Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics, Inc. is overvalued.
Is Allogene Therapeutics, Inc. Stock a Buy?
-
Allogene Therapeutics, Inc. share price is 1.40 while ALLO 8-day exponential moving average is 1.44, which is a Sell signal.
-
The stock price of ALLO is 1.40 while Allogene Therapeutics, Inc. 20-day EMA is 1.42, which makes it a Sell.
-
Allogene Therapeutics, Inc. 50-day exponential moving average is 1.35 while ALLO share price is 1.40, making it a Buy technically.
-
ALLO stock price is 1.40 and Allogene Therapeutics, Inc. 200-day simple moving average is 1.46, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics, Inc.
Is Allogene Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.03 per share.
Technical Analysis of Allogene Therapeutics, Inc.
Should I short Allogene Therapeutics, Inc. stock?
-
ALLO Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Allogene Therapeutics, Inc. is a Buy
-
Allogene Therapeutics, Inc. Relative Strength Index (RSI) is 50.21, which suggest Allogene Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Allogene Therapeutics, Inc. is (1.32 - 1.5), which suggest Allogene Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Allogene Therapeutics, Inc. is (1.11 - 1.37), which suggest Allogene Therapeutics, Inc. is a Buy
* Allogene Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.